Briviact

Active Ingredient(s): Brivaracetam
FDA Approved: * February 18, 2016
Pharm Company: * UCB INC
Category: Anticonvulsant

Brivaracetam, sold under the brand names Briviact and Brivajoy among others, a chemical analog of levetiracetam, is a racetam derivative with anticonvulsant (antiepileptic) properties.[2][3] It is marketed by the pharmaceutical company UCB.[4][5] In India it is co-promoted and distributed by Dr. Reddy's Laboratories.[not verified in body] Contents 1 Medical uses 2 Adverse effects 3 Interactions 4 Pharmacology 4... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Briviact 10 mg Oral Tablet, Film Coated
NDC: 50474-370
Labeler:
Ucb, Inc.
Briviact 25 mg Oral Tablet, Film Coated
NDC: 50474-470
Labeler:
Ucb, Inc.
Briviact 50 mg Oral Tablet, Film Coated
NDC: 50474-570
Labeler:
Ucb, Inc.
Briviact 75 mg Oral Tablet, Film Coated
NDC: 50474-670
Labeler:
Ucb, Inc.
Briviact 100 mg Oral Tablet, Film Coated
NDC: 50474-770
Labeler:
Ucb, Inc.
Briviact 10 mg/ml Oral Solution
NDC: 50474-870
Labeler:
Ucb, Inc.
Briviact 50 mg/5ml Intravenous Injection, Suspension
NDC: 50474-970
Labeler:
Ucb, Inc.